Invention Grant
- Patent Title: Factor II and fibrinogen for treatment of haemostatic disorders
- Patent Title (中): 因子II和纤维蛋白原用于治疗止血障碍
-
Application No.: US13877854Application Date: 2011-09-19
-
Publication No.: US09433664B2Publication Date: 2016-09-06
- Inventor: Ann Lovgren , Kenny Hansson
- Applicant: Ann Lovgren , Kenny Hansson
- Applicant Address: GB Cambridge
- Assignee: MEDIMMUNE LIMITED
- Current Assignee: MEDIMMUNE LIMITED
- Current Assignee Address: GB Cambridge
- Agent Melissa J. Pytel
- International Application: PCT/EP2011/066241 WO 20110919
- International Announcement: WO2012/045569 WO 20120412
- Main IPC: A61K38/48
- IPC: A61K38/48 ; A61K38/36
Abstract:
The present invention relates to normalizing impaired haemostasis comprising administering a clotting factor treatment selected from the group consisting of (1) FII; (2) PCC; and (3) a three factor combination of FH, FX and FVIIa. The clotting factor treatment can be administered in combination with fibrinogen. The clotting factor(s) can be recombinant human clotting factor(s).
Public/Granted literature
- US20130280236A1 FACTOR II AND FIBRINOGEN FOR TREATMENT OF HAEMOSTATIC DISORDERS Public/Granted day:2013-10-24
Information query
IPC分类:
